ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2372

Soluble Triggering Receptor Expressed on Myeloid Cell-1 Reflects the Cross-sectional Activity of Microscopic Polyangiitis and Granulomatosis with Polyangiitis

Jang Woo Ha1, Jason Jungsik Song2, Yong-Beom Park2, Sung Soo Ahn2 and Sang-Won Lee3, 1Yonsei University College of Medicine, Seodaemun-gu, Seoul, South Korea, 2Yonsei University College of Medicine, Seoul, South Korea, 3Yonsei University College of Medicine, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: ANCA associated vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2370–2386) Vasculitis – ANCA-Associated Poster III: Biomarkers & Renal Outcomes

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: This study investigated whether the soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflects the cross-sectional activity of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).

Methods: This study included 47 MPA and 32 GPA patients with well-documented clinical records and stored sera at diagnosis. The activity of vasculitis was assessed using the Birmingham vasculitis activity score (BVAS) The patients were arbitrarily divided into two groups according to BVAS at a frequency of 50% as the upper and lower halves of BVAS.

Results: The median age of the 79 patients was 67.0 years, and 58.2% were women. The median BVAS and sTREM-1 were 12.0 and 513.5 pg/mL. sTREM-1 was significantly correlated with BVAS along with five-factor score, short Form 36 health survey, and C-reactive protein. In the multivariable linear regression analysis, erythrocyte sedimentation rate (standardised β 0.241), and sTREM-1 (standardised β 0.288) were independently correlated with BVAS. Using the receiver operator characteristic curve, the cut-off of sTREM-1 for the upper half of BVAS was set as 474.1 pg/mL. When we divided patients into two groups based on sTREM-1 ≥474.1 pg/mL, MPA and GPA patients with sTREM-1 ≥474.1 pg/mL exhibited a significantly higher risk for the upper half of BVAS than those without (relative risk 5.932). In the multivariable logistic regression analysis with sTREM-1 ≥474 pg/mL, sTREM-1 ≥474 pg/mL (OR 5.662) was independently associated with the upper half of BVAS.

Conclusion: This study is the first to demonstrate that sTREM-1 reflects the cross-sectional activity of MPA and GPA.

Supporting image 1

Table 1. Linear regression analysis of variables for BVAS in patients with MPA and GPA

Supporting image 2

Table 2. Logistic regression analysis of variables for the upper half of BVAS in patients with MPA and GPA

Supporting image 3

Figure 1. Optimal cut-off and relative risk.
(A) Using the ROC curve, sTREM_1 of 474.1 pg/ml was set as the cut-off for the upper half of BVAS. (B) MPA and GPA patients with sTREM_1 ≥474.1 pg/mL exhibited a significantly higher risk for the upper half of BVAS than those without.
ROC: receiver operator characteristic; sTREM_1: soluble triggering receptor expressed on myeloid cells_1; BVAS: Birmingham vasculitis activity score; MPA: microscopic polyangiitis; GPA: granulomatosis with polyangiitis.


Disclosures: J. Ha: None; J. Song: None; Y. Park: None; S. Ahn: None; S. Lee: None.

To cite this abstract in AMA style:

Ha J, Song J, Park Y, Ahn S, Lee S. Soluble Triggering Receptor Expressed on Myeloid Cell-1 Reflects the Cross-sectional Activity of Microscopic Polyangiitis and Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/soluble-triggering-receptor-expressed-on-myeloid-cell-1-reflects-the-cross-sectional-activity-of-microscopic-polyangiitis-and-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/soluble-triggering-receptor-expressed-on-myeloid-cell-1-reflects-the-cross-sectional-activity-of-microscopic-polyangiitis-and-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology